DUPA-FITC
DUPA-FITC is a fluorescent reagent targeting PSMA, which specifically binds to prostate cancer cells expressing PSMA without non-specific binding to normal blood cells. DUPA-FITC can label PSMA-expressing prostate cancer cells in whole blood, followed by internalization and trafficking to acidic intracellular endosomes, during which the fluorescence is quenched. When combined with flow cytometry and density gradient centrifugation enrichment, DUPA-FITC enables quantitative analysis of circulating tumor cells in peripheral blood samples from prostate cancer patients.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1123684-41-2
- Formel: C51H57N7O15S
- Molecular Weight:1040.10
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
DUPA-FITC (1 μM) specifically labels PSMA-expressing LNCaP prostate cancer cells spiked into healthy human whole blood with 93.8% efficiency and exhibits no nonspecific binding to normal blood cells, with an ~8 nM affinity for PSMA[1].
DUPA-FITC (100 nM; 1 h) binds specifically to PSMA-positive LNCaP human prostate cancer cells, with binding abrogated by excess PSMA inhibitor PMPA[2].
DUPA-FITC (100 nM; 1 h) binds specifically to and is internalized by PSMA-positive LNCaP human prostate cancer cells, with fluorescence quenched in acidic intracellular endosomes[2].
Guide (The following is the experimental plan we recommend. This plan serves only as a reference guide. The specific operations should be adjusted according to your actual needs.)
1. Cell preparation: Prepare PSMA-positive cells (such as LNCaP or 22Rv1), or isolate the component rich in CTCs from blood samples through density gradient centrifugation.
2. Washing: Wash the cells twice with a buffer solution (such as PBS containing 1% BSA or 0.1% sodium azide) to remove any excess serum proteins that may interfere with the binding reaction.
3. Incubation: The cells are incubated together with the DUPA-FITC probe in the binding buffer. The commonly used concentration range is 10 nM - 100 nM. The specific concentration can be adjusted according to the affinity of the probe for the study.
Incubation time and temperature: Incubate at 37°C for 1-2 hours to allow the probe to fully bind and undergo partial internalization; if only cell membrane surface staining is performed, incubate on ice for 1 hour.
4. Washing: Wash the cells three times with pre-cooled binding buffer to remove the unbound free probes.
5. Analysis: The cells were analyzed and detected using flow cytometry (FITC channel) or fluorescence microscopy.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS. Nr. 1123684-41-2
-
Molecular Weight 1040.10
-
Formel C51H57N7O15S
-
SMILES
O=C1OC2(C3=CC=C(O)C=C3OC4=CC(O)=CC=C42)C5=CC=C(NC(NCCCCCCCC(N[C@H](C(NCCNC(CC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O)=O)CC6=CC=CC=C6)=O)=S)C=C51
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Flow Cytometry
Flow cytometry (FC) is a technique for high-speed, step-by-step quantitative analysis and sorting of single cells or other biological particles in a suspension by detecting labeled fluorescent signals.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Density Gradient Centrifugation-Based Cell Fractionation (Cell Enrichment Sorting)
Density gradient centrifugation enriches cells by buoyant density: cells sediment during centrifugation until they reach a medium layer or interface compatible with their density, allowing mononuclear cells, granulocytes, erythrocytes, and density-defined subpopulations to be recovered from separate bands or layers. Classic blood-cell applications include Ficoll/sodium-metrizoate or Ficoll-Hypaque enrichment of peripheral blood mononuclear cells, Percoll subfractionation of PBMC and T-cell populations, and Percoll-based neutrophil isolation from whole blood or leukocyte-enriched suspensions. The readout is the physical recovery of enriched cell bands, followed by cell counting, morphology, viability, and immunophenotyping to determine yield, purity, and suitability for downstream assays.
-
Protocol for Phospho-flow cytometry
Phospho-flow cytometry detects intracellular phosphorylated signaling proteins in single cells using phospho-specific antibodies after rapid fixation and permeabilization; the fluorescence intensity reflects phosphorylation state and therefore kinase-pathway activation, inhibition, or drug response in defined cell subsets. Unlike Western blot, phospho-flow preserves single-cell resolution and can measure signaling heterogeneity in cancer cells, primary immune cells, dissociated mouse tumors, macrophages, organoid-derived cells, and drug-screening samples when validated antibodies and fixation/permeabilization conditions are used.
Reinheit & Dokumentation
Verweise
[1]. He W, et al. Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands. Int J Cancer. 2008;123(8):1968-1973. [Content Brief]
[2]. Kularatne SA, et al. Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand. Mol Pharm. 2009;6(3):780-789. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- DUPA-FITC
- 1123684-41-2
- Fluorescent Dye
- circulating tumor cells
- LNCaP human prostate cancer cells
- peripheral blood samples
- normal blood cells
- prostate cancer patients
- flow cytometry
- density gradient centrifugation
- prostate cancer cells
- prostate-specific membrane antigen
- acidic intracellular endosomes
- Inhibitor
- inhibitor
- inhibit